Aurinia Pharmaceuticals Inc XNAS: AUPH

Strong Performer, Getting Expensive

Download real time

12.78 0.56 (4.58%)

New 52W High in past week

2.2M

XNAS Volume

XNAS 11 Sep, 2025 5:30 PM (EDT)

Aurinia Pharmaceuticals Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents